Advertisement

Topics

Reviewing Teva Pharmaceutical Industries Limited (TEVA) & Its Competitors

10:46 EDT 23 Sep 2017 | Topix

Teva Pharmaceutical Industries Limited is one of 112 public companies in the "Pharmaceuticals" industry, but how does it weigh in compared to its competitors? We will compare Teva Pharmaceutical Industries Limited to related businesses based on the strength of its valuation, institutional ownership, earnings, dividends, analyst recommendations, profitability and risk. Teva Pharmaceutical Industries Limited pays an annual dividend of $0.94 per share and has a dividend yield of 5.5%.

Original Article: Reviewing Teva Pharmaceutical Industries Limited (TEVA) & Its Competitors

NEXT ARTICLE

More From BioPortfolio on "Reviewing Teva Pharmaceutical Industries Limited (TEVA) & Its Competitors"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...